The pharmacokinetics (PK) and biodistribution of radiolabeled amyloid-β (Aβ)-targeting probes have been extensively characterized in the context of Alzheimer's disease (AD), whereas the corresponding nonradiolabeled scaffolds remain largely unexplored in vi... ...

请注册登录后继续浏览